January 09, 2008 -Drugs under development by DiaKine Therapeutics to potentially cure diabetes and reverse its complications have been granted a U.S. patent, the company announced at the 26th Annual J.P. Morgan Healthcare Conference in San Francisco. Patent number 7,247,630 covers novel tricyclic compounds that regulate cytokines. Cytokines may mistakenly attack normal organs and tissue and cause diseases such as diabetes and related complications such as kidney and eye disease... [PDF] DiaKine's Press Release-
Thursday, February 7, 2008
DiaKine Therapeutics’ Anti-Inflammatory Drugs
January 09, 2008 -Drugs under development by DiaKine Therapeutics to potentially cure diabetes and reverse its complications have been granted a U.S. patent, the company announced at the 26th Annual J.P. Morgan Healthcare Conference in San Francisco. Patent number 7,247,630 covers novel tricyclic compounds that regulate cytokines. Cytokines may mistakenly attack normal organs and tissue and cause diseases such as diabetes and related complications such as kidney and eye disease... [PDF] DiaKine's Press Release-
